These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 24281134)

  • 1. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study.
    Cleland JG; Chiswell K; Teerlink JR; Stevens S; Fiuzat M; Givertz MM; Davison BA; Mansoor GA; Ponikowski P; Voors AA; Cotter G; Metra M; Massie BM; O'Connor CM
    Circ Heart Fail; 2014 Jan; 7(1):76-87. PubMed ID: 24281134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function trajectories and clinical outcomes in acute heart failure.
    Givertz MM; Postmus D; Hillege HL; Mansoor GA; Massie BM; Davison BA; Ponikowski P; Metra M; Teerlink JR; Cleland JG; Dittrich HC; O'Connor CM; Cotter G; Voors AA
    Circ Heart Fail; 2014 Jan; 7(1):59-67. PubMed ID: 24281137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study.
    O'Connor CM; Fiuzat M; Lombardi C; Fujita K; Jia G; Davison BA; Cleland J; Bloomfield D; Dittrich HC; Delucca P; Givertz MM; Mansoor G; Ponikowski P; Teerlink JR; Voors AA; Massie BM; Cotter G; Metra M
    Circ Heart Fail; 2011 Nov; 4(6):724-32. PubMed ID: 21900185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function.
    Weatherley BD; Cotter G; Dittrich HC; DeLucca P; Mansoor GA; Bloomfield DM; Ponikowski P; O'Connor CM; Metra M; Massie BM;
    J Card Fail; 2010 Jan; 16(1):25-35. PubMed ID: 20123315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
    Ter Maaten JM; Valente MA; Damman K; Cleland JG; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Bloomfield DM; Cotter G; Davison B; Subacius H; van Veldhuisen DJ; van der Meer P; Hillege HL; Gheorghiade M; Voors AA
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27266853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.
    Massie BM; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Cotter G; Weatherley BD; Cleland JG; Givertz MM; Voors A; DeLucca P; Mansoor GA; Salerno CM; Bloomfield DM; Dittrich HC;
    N Engl J Med; 2010 Oct; 363(15):1419-28. PubMed ID: 20925544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT Data.
    Metra M; Cotter G; Senger S; Edwards C; Cleland JG; Ponikowski P; Cursack GC; Milo O; Teerlink JR; Givertz MM; O'Connor CM; Dittrich HC; Bloomfield DM; Voors AA; Davison BA
    Circ Heart Fail; 2018 May; 11(5):e004644. PubMed ID: 29748350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function).
    Voors AA; Dittrich HC; Massie BM; DeLucca P; Mansoor GA; Metra M; Cotter G; Weatherley BD; Ponikowski P; Teerlink JR; Cleland JG; O'Connor CM; Givertz MM
    J Am Coll Cardiol; 2011 May; 57(19):1899-907. PubMed ID: 21545947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
    van Deursen VM; Hernandez AF; Stebbins A; Hasselblad V; Ezekowitz JA; Califf RM; Gottlieb SS; O'Connor CM; Starling RC; Tang WH; McMurray JJ; Dickstein K; Voors AA
    Circulation; 2014 Sep; 130(12):958-65. PubMed ID: 25074507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial.
    Metra M; Mentz RJ; Chiswell K; Bloomfield DM; Cleland JG; Cotter G; Davison BA; Dittrich HC; Fiuzat M; Givertz MM; Lazzarini V; Mansoor GA; Massie BM; Ponikowski P; Teerlink JR; Voors AA; O'Connor CM
    Eur J Heart Fail; 2015 Jan; 17(1):109-18. PubMed ID: 25431336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).
    Lala A; McNulty SE; Mentz RJ; Dunlay SM; Vader JM; AbouEzzeddine OF; DeVore AD; Khazanie P; Redfield MM; Goldsmith SR; Bart BA; Anstrom KJ; Felker GM; Hernandez AF; Stevenson LW
    Circ Heart Fail; 2015 Jul; 8(4):741-8. PubMed ID: 26041600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment.
    Cotter G; Dittrich HC; Weatherley BD; Bloomfield DM; O'Connor CM; Metra M; Massie BM;
    J Card Fail; 2008 Oct; 14(8):631-40. PubMed ID: 18926433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.
    van der Meer P; Postmus D; Ponikowski P; Cleland JG; O'Connor CM; Cotter G; Metra M; Davison BA; Givertz MM; Mansoor GA; Teerlink JR; Massie BM; Hillege HL; Voors AA
    J Am Coll Cardiol; 2013 May; 61(19):1973-81. PubMed ID: 23500313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure.
    Aronson D; Mittleman MA; Burger AJ
    Am J Med; 2004 Apr; 116(7):466-73. PubMed ID: 15047036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models.
    Khazanie P; Heizer GM; Hasselblad V; Armstrong PW; Califf RM; Ezekowitz J; Dickstein K; Levy WC; McMurray JJ; Metra M; Tang WH; Teerlink JR; Voors AA; O'Connor CM; Hernandez AF; Starling R
    Am Heart J; 2015 Aug; 170(2):290-7. PubMed ID: 26299226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
    Davison BA; Metra M; Senger S; Edwards C; Milo O; Bloomfield DM; Cleland JG; Dittrich HC; Givertz MM; O'Connor CM; Massie BM; Ponikowski P; Teerlink JR; Voors AA; Cotter G
    Eur J Heart Fail; 2016 Aug; 18(8):1041-50. PubMed ID: 27114058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction.
    O'Connor CM; Mentz RJ; Cotter G; Metra M; Cleland JG; Davison BA; Givertz MM; Mansoor GA; Ponikowski P; Teerlink JR; Voors AA; Fiuzat M; Wojdyla D; Chiswell K; Massie BM
    Eur J Heart Fail; 2012 Jun; 14(6):605-12. PubMed ID: 22535795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
    J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.